Cargando…
Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
Background: Diarrhoea is the commonest gastrointestinal symptom in patients with common variable immunodeficiency (CVID). Objective: The aim of this study was to describe the prevalence and clinical presentation of chronic and recurrent diarrhoea in the Royal-Free-Hospital (RFH) London CVID cohort,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412961/ https://www.ncbi.nlm.nih.gov/pubmed/32849570 http://dx.doi.org/10.3389/fimmu.2020.01654 |
_version_ | 1783568712380448768 |
---|---|
author | van Schewick, Cornelia M. Nöltner, Christina Abel, Svenja Burns, Siobhan O. Workman, Sarita Symes, Andrew Guzman, David Proietti, Michele Bulashevska, Alla Moreira, Fernando Soetedjo, Veronika Lowe, David M. Grimbacher, Bodo |
author_facet | van Schewick, Cornelia M. Nöltner, Christina Abel, Svenja Burns, Siobhan O. Workman, Sarita Symes, Andrew Guzman, David Proietti, Michele Bulashevska, Alla Moreira, Fernando Soetedjo, Veronika Lowe, David M. Grimbacher, Bodo |
author_sort | van Schewick, Cornelia M. |
collection | PubMed |
description | Background: Diarrhoea is the commonest gastrointestinal symptom in patients with common variable immunodeficiency (CVID). Objective: The aim of this study was to describe the prevalence and clinical presentation of chronic and recurrent diarrhoea in the Royal-Free-Hospital (RFH) London CVID cohort, including symptoms, infections, level of inflammation, and microbial diversity. Methods: A cross-sectional study of adult CVID patients (139 out of 172 diagnosed with CVID completed the screening questionnaire). Those with diarrhoea ≥6 days/month had stool and blood samples analysed and completed the short Inflammatory Bowel Disease Questionnaire (sIBDQ). BMI, spleen-size, lymphocytes and gut-microbial diversity were compared. Due to logistical and clinical restraints, not all patients could be analysed on all measures. Results: 46/139 (33.1%) patients had current significant diarrhoea. In patients with past or present diarrhoea, BMI was lower (median 23.7 vs. 26, p = 0.005), malabsorption more common (57.97 vs. 35.71%, p = 0.011). CD4+ lymphocytes were higher in patients with diarrhoea (p = 0.028; n = 138), but CD4+ naïve lymphocytes were significantly higher in non-diarrhoea patients (p = 0.009, N = 28). Nine patients had confirmed or probable current gastrointestinal infections. Calprotectin was >60 μg/g in 13/29 with significant diarrhoea including 9 without infection. SIBDQ revealed a low median score of 4.74. Microbial alpha diversity was significantly lower in CVID patients compared to healthy household controls. There was no significant difference in alpha diversity in relation to antibiotic intake during the 6 weeks prior to providing samples. Conclusion: Patients with CVID and significant diarrhoea had infections, raised calprotectin, malabsorption, a lower BMI, an impaired quality of life (comparable to active IBD), and they differed from non-diarrhoea patients in their lymphocyte phenotyping. Furthermore, microbial diversity was altered. These findings strongly imply that there may be an inflammatory nature and a systemic predisposition to diarrhoea in CVID, which necessitates further investigation. |
format | Online Article Text |
id | pubmed-7412961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74129612020-08-25 Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea van Schewick, Cornelia M. Nöltner, Christina Abel, Svenja Burns, Siobhan O. Workman, Sarita Symes, Andrew Guzman, David Proietti, Michele Bulashevska, Alla Moreira, Fernando Soetedjo, Veronika Lowe, David M. Grimbacher, Bodo Front Immunol Immunology Background: Diarrhoea is the commonest gastrointestinal symptom in patients with common variable immunodeficiency (CVID). Objective: The aim of this study was to describe the prevalence and clinical presentation of chronic and recurrent diarrhoea in the Royal-Free-Hospital (RFH) London CVID cohort, including symptoms, infections, level of inflammation, and microbial diversity. Methods: A cross-sectional study of adult CVID patients (139 out of 172 diagnosed with CVID completed the screening questionnaire). Those with diarrhoea ≥6 days/month had stool and blood samples analysed and completed the short Inflammatory Bowel Disease Questionnaire (sIBDQ). BMI, spleen-size, lymphocytes and gut-microbial diversity were compared. Due to logistical and clinical restraints, not all patients could be analysed on all measures. Results: 46/139 (33.1%) patients had current significant diarrhoea. In patients with past or present diarrhoea, BMI was lower (median 23.7 vs. 26, p = 0.005), malabsorption more common (57.97 vs. 35.71%, p = 0.011). CD4+ lymphocytes were higher in patients with diarrhoea (p = 0.028; n = 138), but CD4+ naïve lymphocytes were significantly higher in non-diarrhoea patients (p = 0.009, N = 28). Nine patients had confirmed or probable current gastrointestinal infections. Calprotectin was >60 μg/g in 13/29 with significant diarrhoea including 9 without infection. SIBDQ revealed a low median score of 4.74. Microbial alpha diversity was significantly lower in CVID patients compared to healthy household controls. There was no significant difference in alpha diversity in relation to antibiotic intake during the 6 weeks prior to providing samples. Conclusion: Patients with CVID and significant diarrhoea had infections, raised calprotectin, malabsorption, a lower BMI, an impaired quality of life (comparable to active IBD), and they differed from non-diarrhoea patients in their lymphocyte phenotyping. Furthermore, microbial diversity was altered. These findings strongly imply that there may be an inflammatory nature and a systemic predisposition to diarrhoea in CVID, which necessitates further investigation. Frontiers Media S.A. 2020-07-31 /pmc/articles/PMC7412961/ /pubmed/32849570 http://dx.doi.org/10.3389/fimmu.2020.01654 Text en Copyright © 2020 van Schewick, Nöltner, Abel, Burns, Workman, Symes, Guzman, Proietti, Bulashevska, Moreira, Soetedjo, Lowe and Grimbacher. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology van Schewick, Cornelia M. Nöltner, Christina Abel, Svenja Burns, Siobhan O. Workman, Sarita Symes, Andrew Guzman, David Proietti, Michele Bulashevska, Alla Moreira, Fernando Soetedjo, Veronika Lowe, David M. Grimbacher, Bodo Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea |
title | Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea |
title_full | Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea |
title_fullStr | Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea |
title_full_unstemmed | Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea |
title_short | Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea |
title_sort | altered microbiota, impaired quality of life, malabsorption, infection, and inflammation in cvid patients with diarrhoea |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412961/ https://www.ncbi.nlm.nih.gov/pubmed/32849570 http://dx.doi.org/10.3389/fimmu.2020.01654 |
work_keys_str_mv | AT vanschewickcorneliam alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT noltnerchristina alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT abelsvenja alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT burnssiobhano alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT workmansarita alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT symesandrew alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT guzmandavid alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT proiettimichele alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT bulashevskaalla alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT moreirafernando alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT soetedjoveronika alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT lowedavidm alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea AT grimbacherbodo alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea |